Skip to main content
CD11d antibody treatment improves recovery in spinal cord-injured mice
Journal of Neurotrauma
  • Nicole M. Geremia, Robarts Research Institute
  • Feng Bao, Robarts Research Institute
  • Trina E. Rosenzweig, Robarts Research Institute
  • Todd Hryciw, Robarts Research Institute
  • Lynne Weaver, Robarts Research Institute
  • Gregory A. Dekaban, Robarts Research Institute
  • Arthur Brown, Robarts Research Institute
Document Type
Publication Date
URL with Digital Object Identifier

Acute administration of a monoclonal antibody (mAb) raised against the CD11d subunit of the leukocyte CD11d/CD18 integrin after spinal cord injury (SCI) in the rat greatly improves neurological outcomes. This has been chiefly attributed to the reduced infiltration of neutrophils into the injured spinal cord in treated rats. More recently, treating spinal cord-injured mice with a Ly-6G neutrophil-depleting antibody was demonstrated to impair neurological recovery. These disparate results could be due to different mechanisms of action utilized by the two antibodies, or due to differences in the inflammatory responses between mouse and rat that are triggered by SCI. To address whether the anti-CD11d treatment would be effective in mice, a CD11d mAb (205C) or a control mAb (1B7) was administered intravenously at 2, 24, and 48 h after an 8-g clip compression injury at the fourth thoracic spinal segment. The anti-CD11d treatment reduced neutrophil infiltration into the injured mouse spinal cord and was associated with increased white matter sparing and reductions in myeloperoxidase (MPO) activity, reactive oxygen species, lipid peroxidation, and scar formation. These improvements in the injured spinal cord microenvironment were accompanied by increased serotonin (5-HT) immunoreactivity below the level of the lesion and improved locomotor recovery. Our results with the 205C CD11d mAb treatment complement previous work using this anti-integrin treatment in a rat model of SCI. © 2012, Mary Ann Liebert, Inc.

Citation Information
Nicole M. Geremia, Feng Bao, Trina E. Rosenzweig, Todd Hryciw, et al.. "CD11d antibody treatment improves recovery in spinal cord-injured mice" Journal of Neurotrauma Vol. 29 Iss. 3 (2012) p. 539 - 550
Available at: